Medications for Cystinuria

3 results
Par Pharmaceutical, Inc.
Usage: Penicillamine tablets are indicated for treating Wilson’s disease, cystinuria, and severe rheumatoid arthritis that has not responded to conventional therapies. They aid in reducing copper accumulation in Wilson’s disease and managing cystine excretion in cystinuria, while use in rheumatoid arthritis is limited due to potential severe adverse reactions.
Amneal Pharmaceuticals NY LLC
Usage: Tiopronin delayed-release tablets are indicated, along with high fluid intake, alkali, and dietary changes, for preventing cystine stone formation in adults and children aged 9 and older with severe homozygous cystinuria who do not respond to standard treatments.
Biocon Pharma Inc.
Usage: Tiopronin Delayed-Release Tablets are indicated for preventing cystine stone formation in adults and pediatric patients (≥20 kg) with severe homozygous cystinuria, when combined with high fluid intake, alkali, and dietary modifications.